PERBANDINGAN MANFAAT TERAPI ANTIPLATELET KOMBINASI ASPIRIN DAN KLOPIDOGREL DENGAN ASPIRIN TUNGGAL PADA STROKE ISKEMIK DI RSUP Dr. SARDJITO YOGYAKARTA

• Main Authors: , RISMI FATONI, , dr. Abdul Gofir, Sp.S(K)
• 格式: Theses and Dissertations NonPeerReviewed
• 出版: [Yogyakarta] : Universitas Gadjah Mada 2014
• 主題: ETD
• 在線閱讀: https://repository.ugm.ac.id/133311/; http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=73892

Introduction: Percentage incidence of recurrent stroke within the first 30 days after the attack is 3-10% and the risk occurs in the first 6 months is 8.8%. Antiplatelet therapy in patients with ischemic stroke to prevent recurrent stroke. Differences in the results of previous studies related to th...